Shares of Grifols were halted on Monday, following news the indebted Spanish blood plasma pharmaceutical company may go private.
Troubled Spanish pharma company Grifols says it may go private for $6 billion
Read Next
- NVIDIA’s H200 NVL GPU Enhances AI and HPC Applications in Enterprise Servers
- Crypto exchange One Trading employs Solidus Labs compliance and security solutions
- VeBetterDAO Launches Endorsement Mechanism to Empower Decentralized Governance
- RoboForex Receives Best Introducing Broker Programme Award :: InvestMacro
- Cloud software company ServiceTitan files for IPO
- ESMA proposes EU move to T+1 settlement by October 2027
- GitHub Copilot Enhances Code Quality: Study Reveals Significant Improvements
